TT2-32 acetate (TLN-232; CAP-232) is a novel somatostatin analog acting as a peptide agonist for sst1/sst4 somatostatin receptors with antitumor activity. TT-232 inhibited tyrosine kinase activity of tumor cell lines and this inhibition correlated well with the inhibition of cell proliferation of a large number of cancer cell lines in vitro and reduces the size of different tumors in animal models in vivo.

纯度：≥98%

CAS：147159-51-1